Lawmakers Urge FDA To Rethink Drug Labeling

Law360, New York (January 24, 2008, 12:00 AM EST) -- A group of lawmakers has asked the U.S. Food and Drug Administration to reconsider a proposed rule regarding drug labeling, saying it was designed to shield pharmaceutical and device companies from liability for injuries sustained by American consumers as a result of unsafe products.

Eight congressional Democrats led by Rep. Henry A. Waxman, D-Calif., and Sen. Edward M. Kennedy, D-Mass., said in a letter sent Wednesday to FDA Commissioner Andrew von Eschenbach that they are concerned that the proposal is intended to protect companies from being...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.